首页 > 市场调查报告书 > 医疗设备

感测器

市场调查报告书

商品编码

1606546

全球心电图感测器市场 - 2024-2031

Global Electrocardiogram Sensors Market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023年，全球心电图感测器市场规模达94.2亿美元，预计2031年将达到154.1亿美元，2024-2031年预测期间复合年增长率为6.4%。

心电图感测器是评估心臟电活动的心臟状况操作和诊断的重要组成部分。事实上，另一个重要功能包括检测心律不整、心肌梗塞和其他心臟异常，这些功能需要透过医疗管道立即检测和介入。从技术上讲，心电图感测器随着时间的推移而不断发展，从大型机器转变为以智慧手錶、健身追踪器和无线贴片等穿戴式装置的形式紧凑使用，使人们能够轻鬆存取和使用它们。心血管疾病的增加以及针对此的家庭或远端监控和健身追踪服务的需求将会增加。

市场动态：

驱动程式和限制

不断进步的技术

在医疗保健环境中的可能应用的创新和扩展方面，技术进步将在世界心电图 (ECG) 感测器市场上带来巨大变革。例如，小型化、无线连接和人工智慧整合等进步使心电图感测器在准确性方面更加强大，使它们更容易、更友善地操作。借助先进技术，可穿戴心电图感测器现在可以进行即时监测、早期检测低心律不整事件以及个人化的健康见解，使患者能够远端管理自己的心臟健康状况。人工智慧驱动的演算法透过复杂的资料模式分析提高诊断精度，同时减轻医疗保健专业人员的负担。

感测器材料和设计的创新，例如灵活的亲肤贴片，提高了患者的舒适度和依从性。这些符合远距医疗和家庭护理的新兴趋势，将心电图感测器定位为现代医疗保健提供方式之一，但在加速市场成长方面发挥巨大作用。

例如，2023 年 8 月，芬兰医疗设备製造商 Movesense 推出了一款轻型可穿戴心电图感测器“Movesense Medical”，用于远端患者监护和远距医疗应用。 IIa 类设备根据欧盟医疗设备法规註册，供远距医疗保健提供者、製造商、医院或开发自己的医疗设备的公司使用。

缺乏熟练的专业人员

能够正确解释心电图资料的知识丰富的人员的可用性构成了全球心电图 (ECG) 感测器市场的重要限制，特别是在医疗基础设施薄弱的国家。感测器技术和人工智慧引入了各种创新，可以使心电图监测变得更加简单，但复杂心臟讯号的解释通常必须由训练有素的心臟科医生或专家进行。

农村和偏远地区的这种差距进一步限制了获得此类专业知识的机会，从而限制了心电图感测器安装的有效性。此外，由于缺乏人工监督的验证，自动化系统的过度依赖可能会导致误诊，进一步影响对这些设备的信任和采用。这种技能短缺和医疗资源分配不均更阻碍了心电图感测器技术的采用、分配和使用。

ECG sensors are significant constituents of the operation and diagnosis of heart conditions in assessing the heart's electric activity. In fact, another important function includes those in the detection of arrhythmias, myocardial infarctions, and other cardiac abnormalities, which require immediate detection and intervention through medical channelization. Technologically speaking, ECG sensors have evolved over time, changing from large machines to compact use in the form of wearable gadgets like smartwatches, fitness trackers, and wireless patches, making them easy to access and use for people. An increment in cardiovascular diseases and increased demand for home or remote monitoring and fitness-tracking services geared towards that will build.

Market Dynamics: Drivers & Restraints

Increasing Technological Advancements

Advances in technology are set to revolutionize quite a lot in the world electrocardiogram (ECG) sensors market in terms of innovation and extension in possible applications among healthcare settings. For example, advancements like miniaturization, wireless connectivity, and artificial intelligence integration have made ECG sensors much more functional with regard to accuracy, making them easier and more friendly to handle. With the aid of advancement technologies, wearable ECG sensors now allow real-time monitoring, early detection of low arrhythmic events, and personalized health insights, enabling patients to manage their cardiac health from a distance. AI-driven algorithms improve diagnostic precision through complex data pattern analysis while relieving the healthcare professional's burden.

Innovations in sensor materials and designs, such as flexible skin-friendly patches, have brought about increased comfort and compliance with the patient. These are in line with the emergent trends of telemedicine and home-based care, positioning ECG sensors as among the modern healthcare delivery's modalities, but are playing a huge role in accelerating the growth of the market.

For instance, in August 2023, Finnish medical device manufacturer Movesense has introduced a lightweight wearable ECG sensor, 'Movesense Medical', for remote patient monitoring and telehealth applications. The Class IIa device is registered under the EU Medical Device Regulation and is intended for use by remote healthcare providers, manufacturers, hospitals, or companies developing their own medical devices.

Lack of Skilled Professionals

The availability of knowledgeable personnel who can correctly interpret the ECG data present forms an important limitation in the global electrocardiogram (ECG) sensors market, particularly in countries with poor healthcare infrastructure. Sensor technology and AI have introduced various innovations that can make ECG monitoring simpler, but the interpretation of complex cardiac signals often has to be carried out by trained cardiologists or specialists.

This gap in rural and isolated areas further confines access to such expertise, limiting the effectiveness of the ECG sensor installation. Besides, automated systems over-dependence may lead to misdiagnosis due to lack of validation by human oversight, further frowning on the trust and adoption of these devices. This skill shortage and unequal distribution of healthcare resources serve as yet more disincentives to the uptake, distribution, and use of ECG sensor technologies.

Segment Analysis

The global electrocardiogram sensors market is segmented based on product type, connectivity, application, end user and region.

Product type:

Wearable ECG sensors segment is expected to dominate the electrocardiogram sensors market share

The Wearable ECG sensors segment holds a major portion of the electrocardiogram sensors market share and is expected to continue to hold a significant portion of the electrocardiogram sensors market share during the forecast period.

The emergence of wearable ECG sensors will transform the whole electrocardiogram (ECG) sensors market beyond its limits by providing convenient real-time heart monitoring solutions. The demand for remote ongoing care is driving this trend further. Battery-powered miniature, user-friendly devices such as watches, patches, or fitness bands will allow users to continuously monitor their hearts. Especially for arrhythmias, chronic cardiac conditions, and preventive care, these devices will add value. State-of-the-art technologies give AI and Bluetooth-influenced advantages in the area of promising features such as accuracy multiple and easy availability to instant diagnosis.

The continuous advancement gives rise to the use of wearables in home settings with high demand because of an increase in cardiovascular diseases causing maximum consumer awareness of monitoring their health and hence the change towards home and personal healthcare solutions, plus the emergence of the technological landscape. Ultimately, the adoption of wearable ECG sensors resonates with global telemedicine and digital health trends that will not miss being accomplished for future modern needs of the health system and will contribute significantly to its market growth.

For instance, in October 2023, RMIT University in Australia has developed a lightweight, gel-free, and waterproof electrocardiogram (ECG) sensor that offers comfort and less skin irritation compared to other heart monitoring devices. The wearable ECG device, which weighs only 10 grams, could be used to prevent heart attacks in remote healthcare and ambulatory care settings, helping manage cardiovascular disease, which affects around 4 Billion Australians and kills over 100 people daily.

Application:

Arrhythmias segment is the fastest-growing segment in electrocardiogram sensors market share

The arrhythmias segment is the fastest-growing segment in the electrocardiogram sensors market share and is expected to hold the market share over the forecast period.

This market for ECG sensors globally is highly driven by arrhythmias in view of the urgency they present in effective diagnosis and monitoring solutions with which to meet the increasing burden of such irregular heart rhythms. Such conditions as atrial fibrillation, ventricular tachycardia, and bradycardia, which call for extremely continuous and accurate tracking of heart rhythm, have been the catalyst for the rapid adoption of advanced ECG sensors throughout clinical and personal healthcare. The increasing drive for wearable devices that detect real-time arrhythmias, like smartwatches and portable ECG monitors, has given the predicted boost in market revenue.

Technology innovations in sensors, such as AI integration and wireless connectivity, could definitely increase the accuracy and convenience of arrhythmia detection for early intervention and better patient outcomes. Additionally, the rising incidence of arrhythmias in the global world, which is greatly due to increased aging of the population, inactivity lifestyles, and the presence of cardiovascular conditions, makes ECG sensors irreplaceable tools in ensuring heart health and hence a potent driver of market growth.

Geographical Analysis

North America is expected to hold a significant position in the electrocardiogram sensors market share

North America holds a substantial position in the electrocardiogram sensors market and is expected to hold most of the market share due to advanced healthcare infrastructure, a high prevalence of cardiovascular diseases, and a growing inclination toward advanced diagnostic tools for heart health management.

Moreover, North America is also seeing a surge in the adoption of wearable and portable ECG monitoring devices, all against the backdrop of increasing usage of remote patient monitoring and telemedicine services, as boosted through extensive government initiatives and investments in digital health technologies for better early diagnosis and disease management. The development of the market is also aided by the presence of key industry players as well as continuous innovations in sensor technologies such as wireless and AI-enabled ECG devices. Furthermore, an intensely technology-based population and favorable reimbursement policies concerning cardiac diagnostic procedures withhold value to the end users for better adoption of ECG sensors in clinical and personal health applications.

For instance, in May 2024, Defibtech, a US manufacturer of life-saving medical equipment, has introduced dual-language AED models in their Lifeline VIEW and Lifeline ECG product lines. These models allow rescuers to choose English or Spanish as the spoken language with a simple touch of a button. The new AED models are designed to make the devices accessible to more of the population, thereby saving more lives from sudden cardiac arrest. Joseph Mullally, Senior Vice President of Commercial Operations for Defibtech, expressed his satisfaction with the additions.

Europe is growing at the fastest pace in the electrocardiogram sensors market

Europe holds the fastest pace in the electrocardiogram sensors market and is expected to hold most of the market share.

Growing burden of cardiovascular diseases because of this aging population and sedentary lifestyle is what's propelling the ECG sensors market in Europe, along with rising awareness on preventive healthcare. To boost the ECG market, government-sponsored healthcare systems and strong regulatory frameworks ensure the availability and adoption of advanced technologies. Awareness campaigns and initiatives have led to significant acceptance of these devices for continuous and wearable monitoring in the region, emphasizing early detection and management of heart conditions.

Innovations in small, wireless, and integrated AI technology ECG sensors have emerged through collaborative efforts of healthcare providers and technology developers to further increase their use in hospitals and outpatient settings as well as in homes. However, this region continues to stimulate the growth of demand concerning ECG sensors, hence making Europe a substantial contributor to this global market because of its research and development, as well as improvement in healthcare outcomes.

Competitive Landscape

The major global players in the electrocardiogram sensors market include Texas Instruments Inc, Movesense, Unimed Medical Supplies Inc., APK Technology Co., Ltd., Shenzhen Amydi-med Electronic Technology Co., Ltd, Monitor Health, Mobile Sense Technologies Inc., VitalSignum Oy, RONSEDA ELECTRONICS CO.,LTD, KEBORUI among others.

Emerging Players

The emerging players in the electrocardiogram sensors market include AliveCor, Qardio, Inc, FibriCheck and among others.

Key Developments

In June 2024, AliveCor has received FDA clearance for its AI-powered ECG interpretation system and a streamlined handheld ECG system. The pocket-sized system requires minimal training and uses only a single cable, detecting 35 cardiac conditions using a reduced leadset.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global electrocardiogram sensors market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Connectivity & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Connectivity
3.3. Snippet by Application
3.4. Snippet by End User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Technological Advancements
4.2. Restraints
- 4.2.1. Lack of Skilled Professionals
4.3. Opportunity
- 4.3.1. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
- 6.1.2. Market Attractiveness Index, By Product type
6.2. Wearable ECG Sensors *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Patch ECG Sensors
6.4. Wireless ECG Sensors
6.5. Integrated ECG Devices

7. By Connectivity

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
- 7.1.2. Market Attractiveness Index, By Connectivity
7.2. Wired*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Wireless

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Arrhythmia*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Myocardial Infarction
8.4. Others

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals and Clinics*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centers
9.4. Homecare Settings
9.5. Sports and Fitness Centers
9.6. Research Institutes

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Spain
  - 10.3.7.5. Italy
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Texas Instruments Inc*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Movesense
12.3. Unimed Medical Supplies Inc.
12.4. APK Technology Co., Ltd.
12.5. Shenzhen Amydi-med Electronic Technology Co., Ltd
12.6. Monitor Health
12.7. Mobile Sense Technologies, Inc.
12.8. VitalSignum Oy
12.9. RONSEDA ELECTRONICS CO.,LTD
12.10. KEBORUI (LIST NOT EXHAUSTIVE)